Liver News and Research

RSS

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

Natural protein may offer novel therapy to reverse disorders associated with metabolic syndrome

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism.

29 Oct 2018

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis enters into clinical development agreement with Pfizer to improve treatment of NASH

Novartis announced today that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compounds for the treatment of NASH, including an Acetyl CoA-Carboxylase (ACC) Inhibitor (PF-05221304, a Diacylglycerol O-Acyltransferase 2 (DGAT2) Inhibitor (PF-06865571, and a Ketohexokinase (KHK) Inhibitor (PF-06835919).

29 Oct 2018

Getting right level of leptin may help protect cardiovascular health

Getting right level of leptin may help protect cardiovascular health

Like that famous bowl of porridge, when leptin levels are "just right" they help protect our cardiovascular health, scientists say.

29 Oct 2018

Researchers identify new potential target to inhibit progression of liver disease

Researchers identify new potential target to inhibit progression of liver disease

Naglaa Shoukry, Ph. D., and her team have made a significant breakthrough in their research aiming to limit the progression of liver disease.

26 Oct 2018

New 3D 'organ on a chip' could be used to develop new treatments for disease

New 3D 'organ on a chip' could be used to develop new treatments for disease

Researchers have developed a three-dimensional 'organ on a chip' which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.

26 Oct 2018

Gut microbiota can contribute to type 2 diabetes

Gut microbiota can contribute to type 2 diabetes

A study published in the journal Cell shows that the gut microbiota has the ability to affect how cells respond to insulin, and can thus contribute to type 2 diabetes. The findings demonstrate an hereto unknown pathological mechanism.

26 Oct 2018

People overestimate benefits and underestimate risks of medical procedures, shows research

People overestimate benefits and underestimate risks of medical procedures, shows research

From major heart surgery to a course of minor drugs, people overestimate the benefits and underestimate the risks of a variety of medical procedures, according to new research.

25 Oct 2018

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Despite improved survival rates among cancer patients, the risk of death by suicide remains high, especially among those treated for head and neck cancers.

25 Oct 2018

Combination therapy enhances wound healing

Combination therapy enhances wound healing

By incorporating a gene-suppressing drug into an over-the-counter gel, researchers at Albert Einstein College of Medicine and their colleagues cut healing time by half and significantly improved healing outcomes compared to control treatments.

25 Oct 2018

Researchers identify genes responsible for sun sensitivity and skin cancer vulnerability

Researchers identify genes responsible for sun sensitivity and skin cancer vulnerability

Research carried out at the Health Sciences department of the Universitat Jaume I of Castellón, Spain, has identified the genes responsible for sun sensitivity and skin cancer vulnerability.

25 Oct 2018

Alcohol changes the molecular basis of memory formation

Alcohol changes the molecular basis of memory formation

A new study has shown how alcohol consumption fuels addiction by hijacking a conserved memory pathway in the brain and changing memory formation.

25 Oct 2018

Microplastic identified in human waste for the first time

Microplastic identified in human waste for the first time

In a recent analysis of human stool samples, every single sample tested contained microplastic and up to nine different plastics were present.

24 Oct 2018

Scientists identify new target for battling deadly form of leukemia

Scientists identify new target for battling deadly form of leukemia

UT Southwestern scientists, working with colleagues at a sister institution in Houston, have identified a new target for battling a deadly form of leukemia.

24 Oct 2018

New approach using 'cellular dust' offers hope for regenerative medicine

New approach using 'cellular dust' offers hope for regenerative medicine

While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilized using extracellular vesicles (EVs), also known in the past as "cellular dust".

24 Oct 2018

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

Researchers identify a new way to prolong the circulation of cancer-fighting nanoparticles in the bloodstream

For a number of innovative and life-saving medical treatments, from organ replacements and skin grafts to cancer therapy and surgery, success often depends on slipping past or fending off the body's immune system.

24 Oct 2018

SBRT found to be safe treatment for patients with multiple metastases

SBRT found to be safe treatment for patients with multiple metastases

The NRG Oncology clinical trial BR001 tested the hypothesis that stereotactic body radiotherapy could be used safely in oligometastatic patients with multiple metastases.

24 Oct 2018

New partnership aims to tackle cancer health disparities

New partnership aims to tackle cancer health disparities

Although cancer affects all populations in the United States, certain ethnic populations bear a disproportionate burden of cancer compared with other groups, according to the National Cancer Institute.

23 Oct 2018

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL, its dura sealant patch.

23 Oct 2018

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

An interview with Dr.

From Huron Technologies 23 Oct 2018

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.